Management of common femoral artery occlusive disease: A review of endovascular treatment strategies and outcomes
Isolated atherosclerotic lesions of the common femoral artery (CFA) are rare but can produce significant claudication and critical limb ischemia. To date, the “gold standard” treatment for this entity has been common femoral endarterectomy (CFE) with or without patch angioplasty. However, surgery do...
Gespeichert in:
| Veröffentlicht in: | Catheterization and cardiovascular interventions 2019-02, Vol.93 (3), p.514-521 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 521 |
|---|---|
| container_issue | 3 |
| container_start_page | 514 |
| container_title | Catheterization and cardiovascular interventions |
| container_volume | 93 |
| creator | Wong, Gordon Lahsaei, Saba Aoun, Joe Garcia, Lawrence A. |
| description | Isolated atherosclerotic lesions of the common femoral artery (CFA) are rare but can produce significant claudication and critical limb ischemia. To date, the “gold standard” treatment for this entity has been common femoral endarterectomy (CFE) with or without patch angioplasty. However, surgery does have significant early postoperative complications, with a 15% combined mortality/morbidity.
This manuscript sought to perform a comprehensive review of all studies and available data on endovascular treatment of isolated CFA disease and compare its utility to the traditional gold standard treatment. Twenty‐one studies from 1987 to 2018 were included exploring the various CFA endovascular therapies (percutaneous transluminal angioplasty, intravascular stenting, drug‐coated balloons, and directional atherectomy employed to treat CFA disease, in terms of efficacy, safety, and complications). As a conclusion, endovascular interventions provide acceptable short‐term technical outcomes for CFA disease while limiting procedural complications. While only two randomized controlled trials compare short and long‐term outcomes of surgical versus endovascular treatment, further studies are required to clarify the role of endovascular therapy. |
| doi_str_mv | 10.1002/ccd.27983 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2155154443</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2155154443</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3533-a50379136d2e3afd6bc0f1dec88e19d6cd4f44dc9c4ce8da3abbf9f300d514603</originalsourceid><addsrcrecordid>eNp10ctKxDAUgOEgipfRhS8gATe6GM21bdwN4xVG3Ci4K2eSE6m0jSbtyLy91RldCK6SxXd-Qg4hh5ydccbEubXuTOSmkBtkl2shxrnInjfXd25UtkP2UnpljJlMmG2yI5mWuZRil7zfQwsv2GDb0eCpDU0TWuqxCRFqCrHDuKTB2rpP1QKpqxJCwgs6oREXFX58DWHrwgKS7WuItIsI3XcudRE6fKkwUWgdDX031DHtky0PdcKD9TkiT9dXj9Pb8ezh5m46mY2t1FKOQTOZGy4zJ1CCd9ncMs8d2qJAblxmnfJKOWusslg4kDCfe-MlY05zlTE5Iier7lsM7z2mrmyqZLGuocXQp1JwrblWSsmBHv-hr6GP7fC6QRU8F1IrM6jTlbIxpBTRl2-xaiAuS87Krz2Uwx7K7z0M9mhd7OcNul_58_EDOF-Bj6rG5f-lcjq9XCU_Adamk4g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2181723549</pqid></control><display><type>article</type><title>Management of common femoral artery occlusive disease: A review of endovascular treatment strategies and outcomes</title><source>MEDLINE</source><source>Wiley Blackwell Journals</source><creator>Wong, Gordon ; Lahsaei, Saba ; Aoun, Joe ; Garcia, Lawrence A.</creator><creatorcontrib>Wong, Gordon ; Lahsaei, Saba ; Aoun, Joe ; Garcia, Lawrence A.</creatorcontrib><description>Isolated atherosclerotic lesions of the common femoral artery (CFA) are rare but can produce significant claudication and critical limb ischemia. To date, the “gold standard” treatment for this entity has been common femoral endarterectomy (CFE) with or without patch angioplasty. However, surgery does have significant early postoperative complications, with a 15% combined mortality/morbidity.
This manuscript sought to perform a comprehensive review of all studies and available data on endovascular treatment of isolated CFA disease and compare its utility to the traditional gold standard treatment. Twenty‐one studies from 1987 to 2018 were included exploring the various CFA endovascular therapies (percutaneous transluminal angioplasty, intravascular stenting, drug‐coated balloons, and directional atherectomy employed to treat CFA disease, in terms of efficacy, safety, and complications). As a conclusion, endovascular interventions provide acceptable short‐term technical outcomes for CFA disease while limiting procedural complications. While only two randomized controlled trials compare short and long‐term outcomes of surgical versus endovascular treatment, further studies are required to clarify the role of endovascular therapy.</description><identifier>ISSN: 1522-1946</identifier><identifier>EISSN: 1522-726X</identifier><identifier>DOI: 10.1002/ccd.27983</identifier><identifier>PMID: 30537332</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>Aneurysms ; Angioplasty ; Arteriosclerosis ; atherectomy ; Balloon treatment ; balloon, drug coated/eluting ; Cardiovascular diseases ; Cardiovascular system ; Complications ; Constriction, Pathologic ; critical ; directional/rotational ; endovascular intervention ; Endovascular Procedures - adverse effects ; Endovascular Procedures - instrumentation ; Femoral artery ; Femoral Artery - diagnostic imaging ; Femoral Artery - physiopathology ; Femur ; Humans ; Ischemia ; Lesions ; limb ischemia ; Medical equipment ; Medical treatment ; Morbidity ; peripheral arterial disease ; Peripheral Arterial Disease - diagnostic imaging ; Peripheral Arterial Disease - physiopathology ; Peripheral Arterial Disease - therapy ; Risk Factors ; stent, drug eluting ; Surgery ; Time Factors ; Treatment Outcome ; Vascular Patency</subject><ispartof>Catheterization and cardiovascular interventions, 2019-02, Vol.93 (3), p.514-521</ispartof><rights>2018 Wiley Periodicals, Inc.</rights><rights>2019 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3533-a50379136d2e3afd6bc0f1dec88e19d6cd4f44dc9c4ce8da3abbf9f300d514603</citedby><cites>FETCH-LOGICAL-c3533-a50379136d2e3afd6bc0f1dec88e19d6cd4f44dc9c4ce8da3abbf9f300d514603</cites><orcidid>0000-0002-6339-1630</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fccd.27983$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fccd.27983$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30537332$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wong, Gordon</creatorcontrib><creatorcontrib>Lahsaei, Saba</creatorcontrib><creatorcontrib>Aoun, Joe</creatorcontrib><creatorcontrib>Garcia, Lawrence A.</creatorcontrib><title>Management of common femoral artery occlusive disease: A review of endovascular treatment strategies and outcomes</title><title>Catheterization and cardiovascular interventions</title><addtitle>Catheter Cardiovasc Interv</addtitle><description>Isolated atherosclerotic lesions of the common femoral artery (CFA) are rare but can produce significant claudication and critical limb ischemia. To date, the “gold standard” treatment for this entity has been common femoral endarterectomy (CFE) with or without patch angioplasty. However, surgery does have significant early postoperative complications, with a 15% combined mortality/morbidity.
This manuscript sought to perform a comprehensive review of all studies and available data on endovascular treatment of isolated CFA disease and compare its utility to the traditional gold standard treatment. Twenty‐one studies from 1987 to 2018 were included exploring the various CFA endovascular therapies (percutaneous transluminal angioplasty, intravascular stenting, drug‐coated balloons, and directional atherectomy employed to treat CFA disease, in terms of efficacy, safety, and complications). As a conclusion, endovascular interventions provide acceptable short‐term technical outcomes for CFA disease while limiting procedural complications. While only two randomized controlled trials compare short and long‐term outcomes of surgical versus endovascular treatment, further studies are required to clarify the role of endovascular therapy.</description><subject>Aneurysms</subject><subject>Angioplasty</subject><subject>Arteriosclerosis</subject><subject>atherectomy</subject><subject>Balloon treatment</subject><subject>balloon, drug coated/eluting</subject><subject>Cardiovascular diseases</subject><subject>Cardiovascular system</subject><subject>Complications</subject><subject>Constriction, Pathologic</subject><subject>critical</subject><subject>directional/rotational</subject><subject>endovascular intervention</subject><subject>Endovascular Procedures - adverse effects</subject><subject>Endovascular Procedures - instrumentation</subject><subject>Femoral artery</subject><subject>Femoral Artery - diagnostic imaging</subject><subject>Femoral Artery - physiopathology</subject><subject>Femur</subject><subject>Humans</subject><subject>Ischemia</subject><subject>Lesions</subject><subject>limb ischemia</subject><subject>Medical equipment</subject><subject>Medical treatment</subject><subject>Morbidity</subject><subject>peripheral arterial disease</subject><subject>Peripheral Arterial Disease - diagnostic imaging</subject><subject>Peripheral Arterial Disease - physiopathology</subject><subject>Peripheral Arterial Disease - therapy</subject><subject>Risk Factors</subject><subject>stent, drug eluting</subject><subject>Surgery</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>Vascular Patency</subject><issn>1522-1946</issn><issn>1522-726X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10ctKxDAUgOEgipfRhS8gATe6GM21bdwN4xVG3Ci4K2eSE6m0jSbtyLy91RldCK6SxXd-Qg4hh5ydccbEubXuTOSmkBtkl2shxrnInjfXd25UtkP2UnpljJlMmG2yI5mWuZRil7zfQwsv2GDb0eCpDU0TWuqxCRFqCrHDuKTB2rpP1QKpqxJCwgs6oREXFX58DWHrwgKS7WuItIsI3XcudRE6fKkwUWgdDX031DHtky0PdcKD9TkiT9dXj9Pb8ezh5m46mY2t1FKOQTOZGy4zJ1CCd9ncMs8d2qJAblxmnfJKOWusslg4kDCfe-MlY05zlTE5Iier7lsM7z2mrmyqZLGuocXQp1JwrblWSsmBHv-hr6GP7fC6QRU8F1IrM6jTlbIxpBTRl2-xaiAuS87Krz2Uwx7K7z0M9mhd7OcNul_58_EDOF-Bj6rG5f-lcjq9XCU_Adamk4g</recordid><startdate>20190215</startdate><enddate>20190215</enddate><creator>Wong, Gordon</creator><creator>Lahsaei, Saba</creator><creator>Aoun, Joe</creator><creator>Garcia, Lawrence A.</creator><general>John Wiley & Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6339-1630</orcidid></search><sort><creationdate>20190215</creationdate><title>Management of common femoral artery occlusive disease: A review of endovascular treatment strategies and outcomes</title><author>Wong, Gordon ; Lahsaei, Saba ; Aoun, Joe ; Garcia, Lawrence A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3533-a50379136d2e3afd6bc0f1dec88e19d6cd4f44dc9c4ce8da3abbf9f300d514603</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Aneurysms</topic><topic>Angioplasty</topic><topic>Arteriosclerosis</topic><topic>atherectomy</topic><topic>Balloon treatment</topic><topic>balloon, drug coated/eluting</topic><topic>Cardiovascular diseases</topic><topic>Cardiovascular system</topic><topic>Complications</topic><topic>Constriction, Pathologic</topic><topic>critical</topic><topic>directional/rotational</topic><topic>endovascular intervention</topic><topic>Endovascular Procedures - adverse effects</topic><topic>Endovascular Procedures - instrumentation</topic><topic>Femoral artery</topic><topic>Femoral Artery - diagnostic imaging</topic><topic>Femoral Artery - physiopathology</topic><topic>Femur</topic><topic>Humans</topic><topic>Ischemia</topic><topic>Lesions</topic><topic>limb ischemia</topic><topic>Medical equipment</topic><topic>Medical treatment</topic><topic>Morbidity</topic><topic>peripheral arterial disease</topic><topic>Peripheral Arterial Disease - diagnostic imaging</topic><topic>Peripheral Arterial Disease - physiopathology</topic><topic>Peripheral Arterial Disease - therapy</topic><topic>Risk Factors</topic><topic>stent, drug eluting</topic><topic>Surgery</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>Vascular Patency</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wong, Gordon</creatorcontrib><creatorcontrib>Lahsaei, Saba</creatorcontrib><creatorcontrib>Aoun, Joe</creatorcontrib><creatorcontrib>Garcia, Lawrence A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Catheterization and cardiovascular interventions</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wong, Gordon</au><au>Lahsaei, Saba</au><au>Aoun, Joe</au><au>Garcia, Lawrence A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Management of common femoral artery occlusive disease: A review of endovascular treatment strategies and outcomes</atitle><jtitle>Catheterization and cardiovascular interventions</jtitle><addtitle>Catheter Cardiovasc Interv</addtitle><date>2019-02-15</date><risdate>2019</risdate><volume>93</volume><issue>3</issue><spage>514</spage><epage>521</epage><pages>514-521</pages><issn>1522-1946</issn><eissn>1522-726X</eissn><abstract>Isolated atherosclerotic lesions of the common femoral artery (CFA) are rare but can produce significant claudication and critical limb ischemia. To date, the “gold standard” treatment for this entity has been common femoral endarterectomy (CFE) with or without patch angioplasty. However, surgery does have significant early postoperative complications, with a 15% combined mortality/morbidity.
This manuscript sought to perform a comprehensive review of all studies and available data on endovascular treatment of isolated CFA disease and compare its utility to the traditional gold standard treatment. Twenty‐one studies from 1987 to 2018 were included exploring the various CFA endovascular therapies (percutaneous transluminal angioplasty, intravascular stenting, drug‐coated balloons, and directional atherectomy employed to treat CFA disease, in terms of efficacy, safety, and complications). As a conclusion, endovascular interventions provide acceptable short‐term technical outcomes for CFA disease while limiting procedural complications. While only two randomized controlled trials compare short and long‐term outcomes of surgical versus endovascular treatment, further studies are required to clarify the role of endovascular therapy.</abstract><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>30537332</pmid><doi>10.1002/ccd.27983</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-6339-1630</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1522-1946 |
| ispartof | Catheterization and cardiovascular interventions, 2019-02, Vol.93 (3), p.514-521 |
| issn | 1522-1946 1522-726X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2155154443 |
| source | MEDLINE; Wiley Blackwell Journals |
| subjects | Aneurysms Angioplasty Arteriosclerosis atherectomy Balloon treatment balloon, drug coated/eluting Cardiovascular diseases Cardiovascular system Complications Constriction, Pathologic critical directional/rotational endovascular intervention Endovascular Procedures - adverse effects Endovascular Procedures - instrumentation Femoral artery Femoral Artery - diagnostic imaging Femoral Artery - physiopathology Femur Humans Ischemia Lesions limb ischemia Medical equipment Medical treatment Morbidity peripheral arterial disease Peripheral Arterial Disease - diagnostic imaging Peripheral Arterial Disease - physiopathology Peripheral Arterial Disease - therapy Risk Factors stent, drug eluting Surgery Time Factors Treatment Outcome Vascular Patency |
| title | Management of common femoral artery occlusive disease: A review of endovascular treatment strategies and outcomes |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T14%3A25%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Management%20of%20common%20femoral%20artery%20occlusive%20disease:%20A%20review%20of%20endovascular%20treatment%20strategies%20and%20outcomes&rft.jtitle=Catheterization%20and%20cardiovascular%20interventions&rft.au=Wong,%20Gordon&rft.date=2019-02-15&rft.volume=93&rft.issue=3&rft.spage=514&rft.epage=521&rft.pages=514-521&rft.issn=1522-1946&rft.eissn=1522-726X&rft_id=info:doi/10.1002/ccd.27983&rft_dat=%3Cproquest_cross%3E2155154443%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2181723549&rft_id=info:pmid/30537332&rfr_iscdi=true |